Altimmune plans Phase 2 trials in 2025 for pemvidutide in alcohol use disorder and liver disease, highlighting weight loss and liver health benefits.

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...

CagriSema, which is a combination of cagrilintide 2.4-milligram and semaglutide 2.4-mg doses, is being developed so people have a better choice for a weight-loss drug when the patents on Ozempic and ...

Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through its ...

The home shipments — which will be fulfilled by CenterWell Pharmacy — include Wegovy injections of 0.25 mg, 0.5 mg, 1 mg, 1.7 ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...

Novo Nordisk, the manufacturer of Weggovy, is growing its offerings by creating NovoCare Pharmacy, a direct-to-patient (DTP) ...

Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...

Weight loss drugs such as Ozempic and Wegovy are effective but may not suit everyone due to cost or side effects. Incorporating low-GI foods like avocado, chia seeds, and dark chocolate can help ...

While Ozempic is actually intended for people with ... Another option we found progresses each month from 0.2mg to 0.4mg, 0.8mg, 1.2mg, 1.8mg, and finally to 2.2mg at six months.

Celebrity red carpet appearances at the SAG Awards have reignited concerns about their noticeably slimmer figures and fueled speculation over the use of Ozempic, the weight loss medication popular ...

Oscar winner Kathy Bates was among those who openly credited Ozempic for her impressive 100-pound weight loss. Dressed in a sleek black suit, Bates was the epitome of transformation and health.